IRD compared with SABS: revenue, margins and what each company keeps, and the suppliers and customers both name

IRDOpus Genetics, Inc.

Mkt capRevenueRevenue

SABSSAB Biotherapeutics, Inc.

Mkt capRevenueRevenue

Compare

IRDOpus Genetics, Inc.

SABSSAB Biotherapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only IRD 4

VTRSViatrissupplier

—FDA Office of Orphan Drug Productsunlistedsupplier

—Foundation Fighting Blindnessunlistedsupplier

—National Institutes of Healthunlistedsupplier

Shared 0

No shared counterparties.

Only SABS 5

EBSEmergent BioSolutions Canadasupplier

—Avance Clinical PTY, Ltd ("Avance")unlistedsupplier

—Fortrea Holdings Inc. ("Fortrea")unlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Sanford Applied Biosciences

unlistedsupplier

1 more · SABS chain ›

IRDOpus Genetics, Inc.

3.67▼−0.01%

Mkt cap$305.3MRevenue$755,000Q2 FY26Revenue$14MFY25

SABSSAB Biotherapeutics, Inc.

3.33▼−0.49%

Regular sessionNov 2 '26

Mkt cap$304.8MRevenue$114,698Q4 FY24Revenue—

Compare

Regular sessionNov 2 '26

IRDOpus Genetics, Inc.

SABSSAB Biotherapeutics, Inc.

3.67▼−0.01%

Price

3.33▼−0.49%

$305.3M

Mkt cap

$304.8M

Q2 FY26$755,000

Revenue

$114,698Q4 FY24

FY25$14M

Revenue

—

IRD3.67▼−0.01%vsSABS3.33▼−0.49%Regular sessionNov 2 '26